Andorra vs Singapore: Prevalence of anemia among women of reproductive age
Andorra
16.4%
in 2023
Singapore
16.6%
in 2023
Andorra rank
161st
Singapore rank
158th
Prevalence of anemia among women of reproductive age over time
- Andorra
- Singapore
How they compare
Singapore currently reports 16.6% against 16.4% in Andorra, a difference of 0.2%.
Across all 24 years both countries report, Singapore has been ahead every year.
Andorra ranks 161st and Singapore ranks 158th of 192 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Andorra | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.2% | 12.7% | 0.5% | Singapore |
| 2010s | 13.1% | 13.6% | 0.4% | Singapore |
| 2020s | 15.6% | 15.8% | 0.3% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, Andorra or Singapore?
- Singapore, at 16.6% against 16.4% in Andorra as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between Andorra and Singapore?
- 0.2%, with Singapore ahead.
- How many years of comparable data are there for Andorra and Singapore?
- 24 years are reported by both, from 2000 to 2023.
- How do Andorra and Singapore rank globally for prevalence of anemia among women of reproductive age?
- Andorra ranks 161st and Singapore ranks 158th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.